Nippon Shinyaku Co., Ltd. (NPPNY)

Market Cap	2.22B +35.7%
Revenue (ttm)	1.06B +5.9%
Net Income	190.38M -1.8%
EPS	2.83 -1.9%
Shares Out	n/a
PE Ratio	11.67
Forward PE	n/a
Dividend	0.81 (9.69%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Average Volume	10,283
Open	8.41
Previous Close	8.41
Day's Range	8.41 - 8.41
52-Week Range	5.03 - 15.21
Beta	-0.33
RSI	51.61
Earnings Date	Feb 9, 2026

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leb...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1911
• Employees: 2,243
• Stock Exchange: OTCMKTS
• Ticker Symbol: NPPNY

Financial Performance

In fiscal year 2025, Nippon Shinyaku's revenue was 160.23 billion, an increase of 8.08% compared to the previous year's 148.26 billion. Earnings were 32.56 billion, an increase of 25.94%.

Financial numbers in JPY